Identification of synthetic endothelial cell-specific promoters by use of a high-throughput screen

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6209-6221

  Dai, Christine ^a   McAninch, Robin E ^a   Sutton, Richard E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 2; MESSENGER RNA; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; CELL ACTIVITY; CELL LINE; CELL SPECIFICITY; EMBRYO; ENDOTHELIUM CELL; GENE IDENTIFICATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOXIA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT DNA TECHNOLOGY; VESICULAR STOMATITIS VIRUS;

ANTIGENS, CD; BASE SEQUENCE; CELL ADHESION MOLECULES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; GENES, SYNTHETIC; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PROMOTER REGIONS (GENETICS);

EID: 2642550595     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6209-6221.2004     Document Type: Article

References (37)

1. Arai, H., K. Nakao, K. Takaya, K. Hosoda, Y. Ogawa, S. Nakanishi, and H. Imura. 1993. The human endothelin-B receptor gene. Structural organization and chromosomal assignment. J. Biol. Chem. 268:3463-3470.
2. Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340.
3. Bu, X., and T. Quertermous. 1997. Identification of an endothelial cell-specific regulatory region in the murine endothelin-1 gene. J. Biol. Chem. 272:32613-32622.
4. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
5. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899-909.
6. Cowan, P. J., D. Tsang, C. M. Pedic, L. R. Abbott, T. A. Shinkel, A. J. d'Apice, and M. J. Pearse. 1998. The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites. J. Biol. Chem. 273:11737-11744.
7. Cowan, S., T. Hatziioannou, T. Cunningham, M. A. Muesing, H. G. Gottlinger, and P. D. Bieniasz. 2002. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99:11914-11919.
8. Edelman, G. M., R., Meech, G. C. Owens, and F. S. Jones. 2000. Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity. Proc. Natl. Acad. Sci. USA 97:3038-3043.
9. Goldman, C. K., and G. Y. Gillespie. 1995. Physiologic responses of REVC, a continuous rabbit endothelial vascular cell. J. Vasc. Res. 32:31-40.
10. Gumina, R. J., N. E. Kirschbaum, K. Piotrowski, and P. J. Newman. 1997. Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89:1260-1269.
11. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256.
12. Hata, Y., E. Duh, K. Zhang, G. S. Robinson, and L. P. Aiello. 1998. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J. Biol. Chem. 273:19294-19303.
13. Hatziioannou, T., S. Cowan, S. P. Goff, P. D. Bieniasz, and G. J. Towers. 2003. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22:385-394.
14. Ikeda, T., K. Wakiya, and M. Shibuya. 1996. Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor. Growth Factors 13:151-162.
15. Kohn, D. B., M. Sadelain, and J. C. Glorioso. 2003. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3:477-488.
16. Kootstra, N. A., C. Munk, N. Tonnu, N. R. Landau, and I. M. Verma. 2003. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. USA 100:1298-1303.
17. Kostic, C., F. Chiodini, P. Salmon, M. Wiznerowicz, N. Deglon, D. Hornfeld, D. Trono, P. Aebischer, D. F. Schorderet, F. L. Munier, and Y. Arsenijevic. 2003. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther. 10:818-821.
18. Kuriyama, S., M. Yoshikawa, S. Ishizaka, T. Tsujii, K. Ikenaka, T. Kagawa, N. Morita, and K. Mikoshiba. 1991. A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector. Cell Struct. Funct. 16:503-510.
19. Lee, M. E., M. S. Dhadly, D. H. Temizer, J. A. Clifford, M. Yoshizumi, and T. Quertermous. 1991. Regulation of endothelin-1 gene expression by Fos and Jun. J. Biol. Chem. 266:19034-19039.
20. Li, X., E. M. Eastman, R. J. Schwartz, and R. Draghia-Akli. 1999. Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol. 17:241-245.
21. Liu, Y., S. R. Cox, T. Morita, and S. Kourembanas. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77:638-643.
22. May, C., S. Rivella, J. Callegari, G. Heller, K. M. Gaensler, L. Luzzatto, and M. Sadelain. 2000. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406:82-86.
23. Meacock, S., R. Pescini-Gobert, J. F. DeLamarter, and R. Hooft van Huijsduijnen. 1994. Transcription factor-induced, phased bending of the E-selectin promoter. J. Biol. Chem. 269:31756-31762.
24. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
25. Miyoshi, H., M. Takahashi, F. H. Gage, and I. M. Verma. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94:10319-10323.
26. Munk, C., S. M. Brandt, G. Lucero, and N. R. Landau. 2002. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA 99:13843-13848.
27. Pawliuk, R., K. A. Westerman, M. E. Fabry, E. Payen, R. Tighe, E. E. Bouhassira, S. A. Acharya, J. Ellis, I. M. London, C. J. Eaves, R. K. Humphries, Y. Beuzard, R. L. Nagel, and P. Leboulch. 2001. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 294:2368-2371.
28. Piret, J. P., D. Mottet, M. Raes, and C. Michiels. 2002. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N. Y. Acad. Sci. 973:443-447.
29. Quinonez, R., and R. E. Sutton. 2002. Lentiviral vectors for gene delivery into cells. DNA Cell Biol. 21:937-951.
30. Ronicke, V., W. Risau, and G. Breier. 1996. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ. Res. 79:277-285.
31. Sutton, R. E., H. T. Wu, R. Rigg, E. Bohnlein, and P. O. Brown. 1998. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72:5781-5788.
32. Tornoe, J., P. Kusk, T. E. Johansen, and P. R. Jensen. 2002. Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites. Gene 297:21-32.
33. Valdenaire, O., E. Rohrbacher, and M. G. Mattei. 1995. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270:29794-29798.
34. Wilson, D. B., D. M. Dorfman, and S. H. Orkin. 1990. A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol. Cell. Biol. 10:4854-4862.
35. Wu, X., J. Holschen, S. C. Kennedy, and K. P. Ponder. 1996. Retroviral vector sequences may interact with some internal promoters and influence expression. Hum. Gene Ther. 7:159-171.
36. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
37. Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72:9873-9880.